Individuals* eligible for the polypill and separate medication (% of total population)
| Risk threshold | Polypill | Separate medication | ||||||||||||||||
| Men | Women | Total | Men | Women | Total | |||||||||||||
| 5% | 7.5% | 10% | 5% | 7.5% | 10% | 5% | 7.5% | 10% | 5% | 7.5% | 10% | 5% | 7.5% | 10% | 5% | 7.5% | 10% | |
| Age, years | ||||||||||||||||||
| 40–49 | 9.1 | 2.2 | 0.4 | 0.0 | 0.0 | 0.0 | 4.0 | 1.0 | 0.2 | 8.7 | 2.1 | 0.4 | 0.0 | 0.0 | 0.0 | 3.8 | 0.9 | 0.2 |
| 50–59 | 61.3 | 38.3 | 22.7 | 6.0 | 1.7 | 0.5 | 32.1 | 19.0 | 11.0 | 50.7 | 32.8 | 20.1 | 5.8 | 1.7 | 0.5 | 27.2 | 16.5 | 9.8 |
| 60–69 | 98.8 | 93.4 | 83.5 | 72.1 | 47.5 | 30.0 | 85.7 | 70.9 | 57.2 | 74.9 | 73.3 | 68.1 | 61.3 | 41.2 | 26.5 | 68.2 | 57.6 | 47.7 |
| 70–75 | 98.9 | 98.9 | 98.4 | 100.0 | 97.0 | 87.0 | 99.4 | 98.0 | 92.9 | 72.7 | 72.7 | 72.7 | 76.3 | 75.8 | 71.1 | 74.5 | 74.2 | 71.9 |
| All ages (40–75) | 57.4 | 46.2 | 37.7 | 25.0 | 18.0 | 13.1 | 40.3 | 31.3 | 24.7 | 46.2 | 37.8 | 31.5 | 21.9 | 16.0 | 11.9 | 33.4 | 26.3 | 21.2 |
↵* Not yet using statins or antihypertensives.